Free Trial
NASDAQ:LMNS

Lumenis (LMNS) Stock Price, News & Analysis

→ Move Your Money Before May 22 (From Stansberry Research) (Ad)
Free LMNS Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
LMNS stock logo

About Lumenis Stock (NASDAQ:LMNS)

Lumenis Ltd. (Lumenis) is a provider of energy-based, minimally invasive clinical solutions. The Company operates through three segments: surgical, ophthalmic and aesthetic. The Company offers energy-based solutions for medically necessary and elective procedures, primarily for the aging population. Its solutions include the holmium laser, the Lumenis Pulse 120H, used for urologic applications; the VersaPulse PowerSuite platform which uses holmium lasers for urologic applications; the M22 multi-energy, a multi-application platform for the treatment of various skin conditions, and the Selecta multi-modality platform for retinal, secondary cataract and glaucoma therapies. It offers products to hospitals, outpatient clinics, ambulatory surgery centers, physicians' offices, private clinics and aesthetic chains. Its locations include Yokneam, Israel, where surgical and aesthetic products are manufactured, and Salt Lake City, Utah, where ophthalmic products are manufactured.

LMNS Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive LMNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lumenis and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/12/2015
Today
4/26/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:LMNS
CUSIP
N/A
CIK
1004945
Web
www.lumenis.com
Phone
+972-4-9599000
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover
Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Harel Beit-On (Age 52)
    Chairman of the Board
  • Zipora Ozer-Armon (Age 51)
    Chief Executive Officer
  • Ophir Yakovian
    Chief Financial Officer
  • Qiying Zhai
    Senior Vice President and Regional President, Lumenis China
  • Eran Cohen (Age 57)
    Vice President - Global Operations
  • Elad Benjamin
    Vice President and General Manager - Surgical Strategic Business Unit
  • Hadas Padan
    Vice President and General Manager Vision Strategic Business Unit
  • Roy Ramati
    Vice President, General Manager - Aesthetic Strategic Business Unit
  • Kfir Azoulay
    Vice President - Corporate Marketing
  • Ido Ben-Tov
    Vice President - Service

LMNS Stock Analysis - Frequently Asked Questions

How were Lumenis' earnings last quarter?

Lumenis Ltd. (NASDAQ:LMNS) released its quarterly earnings data on Tuesday, May, 12th. The medical equipment provider reported $0.06 earnings per share for the quarter, missing analysts' consensus estimates of $0.11 by $0.05. The medical equipment provider had revenue of $68.51 million for the quarter, compared to analyst estimates of $68.36 million. The firm's revenue for the quarter was up 4.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.07 earnings per share.

What other stocks do shareholders of Lumenis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lumenis investors own include Supernus Pharmaceuticals (SUPN), Aralez Pharmaceuticals (ARLZ), Omeros (OMER), Performant Financial (PFMT), Wright Medical Group (WMGI), Biocept (BIOC), Bausch Health Companies (BHC), Bioanalytical Systems (BASI), Avadel Pharmaceuticals (AVDL) and Aptevo Therapeutics (APVO).

This page (NASDAQ:LMNS) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
These AI trades triggered this morning (545% return)
Prosper Trading Academy
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
He Is Giving Away Bitcoin
Crypto Swap Profits
Man Who Predicted 2008: “This Will be Worse.”
Altimetry
Emergency: Biden's $20 Trillion Mistake Could Cost YOU!
GoldenCrest Metals
Fed launches fourth dollar overhaul
Stansberry Research